|
Brief Reports
Citations 81-90 of 1234 total displayed.
|
Past content
(since Jul 1999):
|
The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication
- Aline Renneville, Nicolas Boissel, Nathalie Gachard, Dina Naguib, Christian Bastard, Stéphane de Botton, Olivier Nibourel, Cécile Pautas, Oumedaly Reman, Xavier Thomas, Claude Gardin, Christine Terré, Sylvie Castaigne, Claude Preudhomme, and Hervé Dombret
Blood 2009; 113: 5090-5093.
[Abstract]
[Full text]
[PDF]
The mouse Runx1 +23 hematopoietic stem cell enhancer confers hematopoietic specificity to both Runx1 promoters
- Thomas Bee, Emma L.K. Ashley, Sorrel R.B. Bickley, Andrew Jarratt, Pik-Shan Li, Jackie Sloane-Stanley, Berthold Göttgens, and Marella F.T.R. de Bruijn
Blood 2009; 113: 5121-5124.
[Abstract]
[Full text]
[PDF]
Reduction of T cell–derived ghrelin enhances proinflammatory cytokine expression: implications for age-associated increases in inflammation
- Vishwa D. Dixit, Hyunwon Yang, Anthony Cooper-Jenkins, Banabihari B. Giri, Kalpesh Patel, and Dennis D. Taub
Blood 2009; 113: 5202-5205.
[Abstract]
[Full text]
[PDF]
The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome
- Selcuk Sozer, Maria Isabel Fiel, Thomas Schiano, Mingjiang Xu, John Mascarenhas, and Ronald Hoffman
Blood 2009; 113: 5246-5249.
[Abstract]
[Full text]
[PDF]
NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS)
- Friederike Schneider, Eva Hoster, Michael Unterhalt, Stephanie Schneider, Annika Dufour, Tobias Benthaus, Gudrun Mellert, Evelin Zellmeier, Stefan K. Bohlander, Michaela Feuring-Buske, Christian Buske, Jan Braess, Susanne Fritsch, Achim Heinecke, Maria C. Sauerland, Wolfgang E. Berdel, Thomas Buechner, Bernhard J. Woermann, Wolfgang Hiddemann, and Karsten Spiekermann
Blood 2009; 113: 5250-5253.
[Abstract]
[Full text]
[PDF]
R2* magnetic resonance imaging of the liver in patients with iron overload
- Jane S. Hankins, M. Beth McCarville, Ralf B. Loeffler, Matthew P. Smeltzer, Mihaela Onciu, Fredric A. Hoffer, Chin-Shang Li, Winfred C. Wang, Russell E. Ware, and Claudia M. Hillenbrand
Blood 2009; 113: 4853-4855.
[Abstract]
[Full text]
[PDF]
Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia
- Marcia Bellon, Yves Lepelletier, Olivier Hermine, and Christophe Nicot
Blood 2009; 113: 4914-4917.
[Abstract]
[Full text]
[PDF]
The NF- B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
- Urban Novak, Andrea Rinaldi, Ivo Kwee, Subhadra V. Nandula, Paola M. V. Rancoita, Mara Compagno, Michaela Cerri, Davide Rossi, Vundavalli V. Murty, Emanuele Zucca, Gianluca Gaidano, Riccardo Dalla-Favera, Laura Pasqualucci, Govind Bhagat, and Francesco Bertoni
Blood 2009; 113: 4918-4921.
[Abstract]
[Full text]
[PDF]
Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy
- Virginia Pérez-Andreu, Vanessa Roldán, Ana Isabel Antón, Nuria García-Barberá, Javier Corral, Vicente Vicente, and Rocio González-Conejero
Blood 2009; 113: 4977-4979.
[Abstract]
[Full text]
[PDF]
Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease
- Mark Bower, Ophelia Veraitch, Richard Szydlo, Peter Charles, Peter Kelleher, Brian Gazzard, Mark Nelson, and Justin Stebbing
Blood 2009; 113: 4521-4524.
[Abstract]
[Full text]
[PDF]
|
|
